Equip yourself with the latest advancements and recommendations in endocrinology. With ENDO 2024 Session Recordings, you can learn from leading experts anytime, anywhere.
Relive the highlights or catch up on what you missed with ENDO 2024 Session Recordings. Gain access to over 140 sessions that explore every facet of hormone health and science, including Plenaries, Meet the Professor sessions, Symposia, Professional Development Workshops, and more!
Earn up to 145.25 AMA PRA Category 1 Credits™ while you learn at your own pace and from anywhere.
Topical categories include:
Gain unlimited access to over 140 sessions from ENDO 2024. The package includes:
The Endocrine Society designates each activity in this course for a maximum of 145.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
Credit expiration date: December 31, 2026
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following AMSC members reported relevant financial relationships:
Irina Bancos, MD, Elsevier, writer, Dynamed, reviewer, Endocrine Society Educational initiatives
Stephanie Anne Fish, PhD, American Board of Internal Medicine, write questions for endocrine maintenance of certification
Lauren Michelle Fishbein, MD, PhD, Lantheus/Azedra, Consultant, Endocrine Society, Associate Editor Endocrine Review
Christa E. Flueck, MD, Novo Nordisk, advisor, grantee, Merck, grantee, Pfizer, advisor, grantee, Sandoz, grantee, speaker, EffRx, advisor, Swiss National Science Foundation, grantee, European Society Paediatric Endocrinology, grantee, committee member
Daniel E. Frigo, PhD, -GTx, Inc, paid consultant and laboratory funding, Hummingbird Bioscience, Maia Biotechnology,-Alms Therapeutics,-Barricade Therapeutic, -Hinova Pharmaceuticals, Inc.
Ole-Petter Hamnvik, MBBChBAO, MMSc, MRCPI, Education Editor: New England Journal of Medicine
Edward Chiaming Hsiao, MD, PhD, Clementia Pharmaceuticals/Ipsen Pharmaceuticals: Clinical trials site investigator at UCSF, Ultragenyx: Clinical trials site investigator at UCSF
Shingo Kajimura, PhD, Seminar Speaker, Novo Nordisk, Eli Lilly Amgen
Niki Karavataki, MSc, PhD, FRCP, Recordati Rare Diseases, Speaker, HRA Pharma, Speaker, Editorial Board, Pfizer, Speaker, Ipsen, Speaker, Conselient Health, Speaker
Katja Kiseljak-Vassiliades, DO, HRA Pharma, Adrenocortical carcinoma Advisory Board
Ellis R. Levin, MD, Stock Owner: Gilead Inc., Amgen
Raghavendra Mirmira, PhD, MD, Editor: Journal of Clinical Endocrinology and Metabolism, Advisory Board: Veralox Therapeutics
Gabrielle Page-Wilson, MD, Advisory Board: Strongbridge Biopharma, Recordati Rare Diseases, Inc., Xeris BioPharma; Consultant: Xeris BioPharma
Matti Poutanen, PhD, Aboendo, Founder & CEO, Forendo Pharma, Advisor, Organon Co., Advisor
Yumie Rhee, MD, PhD, Associate Editor, JCEM Case Reports
W. Edward Visser, MD, PhD, Royalties (Institution): Egetis Therapeutics
Selma Witchel, MD, Journal of the Endocrine Society, Editorial Board, Steroids, Associate Editor
Bu Beng Yeap, MBBS, FRACP, PhD, Advisory Board: NovoNordisk, Bayer, Advisor: Lawley Pharmaceuticals, Speaker: AstraZeneca, Besins, Philippine Society for Endocrinology, Diabetes and Metabolism, View Street Medical, President: Endocrine Society of Australia, Associate Editor: Asian Journal of Andrology, Journal of Gerontology Medical Sciences, Editorial Board: Journal of Gerontology Medical Sciences, Journal of Clinical Endocrinology and Metabolism, Maturitas
Elaine Wei-Yin Yu, MD, Grant Recipient: Amgen, Stock Owner: Opko
The following AMSC members reported no relevant financial relationships:
Ana Paula Abreu, MD, PhD; Benson Akingbemi, PhD, DVM; Olga Astapova, MD, PhD; Denise Belsham, PhD; Ernesto Bernal-Mizrachi, MD; Daniel Bernard, PhD; Laura Boucai, MD; Davide Calebiro, MD, Barbara Gisella Carranza Leon, MD; Aime Franco, PhD; Hebatullah Ismail, MD; Carolin Hurtado, MD; Srividya Kidambi, MD; T. Raj Kumar, PhD, MPHIL, MSC; Erik Nelson, BSc, PhD; Claire Newton, BSc, PhD; Bernice Omotosho, MD; Ines Pineda Torra PhD; Claudia Ramirez, MD; Kanakadurga Singer, MD; Dominique Stephens, PhD; Marc J. Tetel, PhD; and Jun Yang, MBBS, PhD, FRACP.
Disclosure information for presenters is included in their individual recorded presentations.
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships
Content Licensing
Contact us to learn more about licensing solutions for your organization.